Search

Home > Diabetes Knowledge into Practice Podcast > Clinical inertia: the dangers of delay & tips to address it


	Podcast:		Diabetes Knowledge into Practice Podcast
	Episode:		Clinical inertia: the dangers of delay & tips to address it
	Category:		Health
	Duration:		00:15:22
	Publish Date:		2019-12-02 05:00:00
	Description:		Featuring an interview with Dr Alexander Miras of Imperial college London. This episode takes a closer look at clinical inertia, and how even a 1 year delay in treatment intensification can lead to significantly increased risk of poor patient outcomes. References Khunti S, et al. Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia. Ther Adv Endocrinol Metab. 2019;10:2042018819844694. Lin J, et al. Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US. Clinicoecon Outcomes Res. 2016;9:19–29. Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review. Prim Care Diabetes. 2017 Feb;11(1):3-12. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–3417. This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.
	Total Play:		0